Ting Wu of Haiwen & Partners raises some questions to highlight how China's newly implemented drug patent linkage system attempts to resolve drug patent disputes in the early stages, which will have a sweeping impact on market entry strategies for chemical drugs in China
Features & Analyses
- August 13, 2021
Several major Chinese law firms have set up new offices in Hainan since 2018
August 06, 2021The expansion of competing U.S.-China sanctions requirements are forcing multinationals to rethink their traditional global compliance strategies
July 30, 2021Andrew Sim and Alanna Rennie of Baker McKenzie discuss the key provisions of the new Judicial Interpretation on plant variety rights (PVR), which will encourage more consistent rulings by the people's court and grant stronger judicial protection to PVR holders in China
July 22, 2021PRC companies wanting to list outside China face extended cybersecurity reviews and potentially burdensome documentation submission requirements
July 16, 2021Beilei Hou and Zi Ling of King & Wood Mallesons look at the emerging carbon emissions trading scheme in China, and consider the outlook for market access to foreign investors
July 09, 2021First high-profile cybersecurity reviews indicate that overseas-listed Chinese tech firms are prime targets for new cybersecurity regime
July 08, 2021Rongwei (Ron) Cai, Jianwei (Jerry) Fang, and Dianmeng Zhu of Zhong Lun Law Firm introduce the newly enacted PRC Data Security Law, highlight the core data security protection obligations imposed on companies, and set out steps companies should be taking immediately in order to ensure compliance
July 04, 2021New China asset management rules tighten requirements on the due diligence of distributors
June 30, 2021Industry coverage, allowance allocation, and compliance obligations are all expected to be ramped up under China's national carbon emissions trading scheme
June 25, 2021










